Key Record Dates
ClinicalTrials.gov Identifier: | NCT05162443 |
---|---|
Brief Title: | Expanded Access of Adagrasib (MRTX849) in Patients With Advanced Solid Tumors Who Have a KRAS G12C Mutation |
First Submitted : | December 3, 2021 |
First Submitted that Met QC Criteria : | December 3, 2021 |
First Posted : | December 17, 2021 |
Last Update Submitted that Met QC Criteria : | May 17, 2023 |
Last Update Posted : | May 19, 2023 |